AI-generated from publicly available materials.Rocket Doctor AI Inc. has reported significant growth in both revenue and patient visits in its latest quarterly update, indicating a robust expansion in its digital health services.
For the second quarter ending June 30, 2026, Rocket Doctor achieved revenues of CA$734,028, reflecting a 43% increase compared to CA$512,756 during the same period last year. This growth aligns closely with the CA$737,103 reported in the previous quarter. Notably, U.S. patient visits surged by 196% from 1,319 to 3,911, coinciding with an expansion of its clinician network from 19 to 30 active providers. The company currently has a total of 80 providers, with many in the credentialing process. In Canada, patient visits rose 23% year-over-year.
CEO Dr. Essam Hamza attributed this growth to strategic payer agreements in the U.S., now covering approximately 24 million lives across California, Maryland, and New York State. Despite these gains, the company reported a net loss of CA$6.67 million for the quarter, which is an increase from CA$4.64 million in the prior quarter and CA$2.69 million a year earlier. The gross margin decreased to 65%, down from 75% in the previous quarter, reflecting the evolving revenue mix as the company scales its operations.
Looking ahead, Rocket Doctor's revenue recognition strategy, particularly in the U.S., may lead to a delayed financial impact from the recent increase in patient visits. The company is also focusing on expanding its insurance coverage and has initiated several partnerships, including a notable agreement for value-based primary care. These developments suggest a promising trajectory for Rocket Doctor as it continues to enhance its digital health platform while navigating the challenges of scaling in a competitive market.